Peptide Receptor Radionuclide Therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Peptide Receptor Radionuclide Therapy, covering 2026-04-22 to 2026-08-28. Get the full timeline:
Most recent: Clinical Trial Results: Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases [Phase 2]